Clinical Trial Planning & Design
Supporting statistically sound study decisions from protocol development through study initiation.
Clinical development biostatistics
Supporting biotechnology and pharmaceutical sponsors with protocol development, SAP authoring, sample size justification, regulatory submissions, and inspection-ready statistical deliverables across Phase I–III clinical trials.
Strategic Biostatistics
Clinical Development Support
Independent Statistical Review
QC, Validation & Oversight
Regulatory Submission Support
Inspection-Ready Deliverables
Services Overview
Strategic biostatistical support across the clinical development lifecycle — from study design through regulatory submission.
Supporting statistically sound study decisions from protocol development through study initiation.
Developing analysis strategies aligned with study objectives and regulatory expectations.
Supporting trial conduct, interim decisions, and ongoing statistical needs.
Transforming clinical data into meaningful statistical evidence.
Providing independent review to strengthen quality and submission readiness.
Supporting preparation of statistically rigorous regulatory deliverables.
Why Work With PrecisionStats Consulting
PrecisionStats Consulting provides focused biostatistical leadership for sponsors and clinical teams seeking reliable statistical guidance, regulatory-ready deliverables, and a collaborative partner throughout the clinical development lifecycle.
With experience supporting Phase I–III studies, regulatory activities, and cross-functional teams, PrecisionStats Consulting helps organizations make informed decisions while maintaining scientific rigor and quality.
Support from a biostatistician who understands study design, execution, analysis, and submission requirements.
Direct collaboration with an experienced statistical lead supporting clinical, regulatory, data, and development teams.
Provide objective statistical perspective to strengthen quality, consistency, and confidence in clinical deliverables.
Support aligned with ICH principles, CDISC standards, and regulatory submission expectations.
Access specialized biostatistical expertise tailored to study needs, timelines, and development milestones.
Next step